Therapeutic Drug Monitoring in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
Open Access
- 1 January 2003
- journal article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 127 (1) , 102-105
- https://doi.org/10.5858/2003-127-102-tdmihi
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- The economics of HIV in AfricaThe Lancet, 2002
- Critical Issues in Therapeutic Drug Monitoring of Antiretroviral DrugsTherapeutic Drug Monitoring, 2002
- High-Performance Liquid Chromatographic Method for the Simultaneous Determination of the Six HIV-Protease Inhibitors and Two Non-Nucleoside Reverse Transcriptase Inhibitors in Human PlasmaTherapeutic Drug Monitoring, 2002
- Concentration-controlled compared with conventional antiretroviral therapy for HIV infectionAIDS, 2002
- Simple rapid method for quantification of antiretrovirals by liquid chromatography—tandem mass-spectrometryClinical Biochemistry, 2002
- Review: Therapeutic Drug Monitoring in PediatricsTherapeutic Drug Monitoring, 2002
- Pharmacokinetic and Pharmacodynamic Study of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir after Multiple Oral DosingAntimicrobial Agents and Chemotherapy, 2001
- Using Pharmacokinetics to Optimize Antiretroviral Drug-Drug Interactions in the Treatment of Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2000
- Effect of Antiretroviral Therapy on Viral Load, CD4 Cell Count, and Progression to Acquired Immunodeficiency Syndrome in a Community Human Immunodeficiency Virus–Infected CohortArchives of internal medicine (1960), 2000
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort studyThe Lancet, 1999